--- title: "12 Health Care Stocks Moving In Tuesday's After-Market Session" type: "News" locale: "en" url: "https://longbridge.com/en/news/296271006.md" description: "During Tuesday's after-market session, several healthcare stocks experienced significant volatility. Tenon Medical surged 70.3% to $9.28, while HCW Biologics rose 10.79%. Other gainers included Pulmonx, Curis, Apimeds Pharmaceuticals, and Longeveron. Conversely, IM Cannabis dropped 13.7%, Akso Health fell 11.22%, and SILO Pharma declined 9.78%. Most movements followed recent Q2 earnings reports." datetime: "2026-08-18T21:06:15.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/296271006.md) - [en](https://longbridge.com/en/news/296271006.md) - [zh-HK](https://longbridge.com/zh-HK/news/296271006.md) generator: "portal-rs" --- # 12 Health Care Stocks Moving In Tuesday's After-Market Session ### Gainers - **Tenon Medical** (NASDAQ:TNON) shares moved upwards by 70.3% to $9.28 during Tuesday's after-market session. The market value of their outstanding shares is at $3.2 million. The company's, Q2 earnings came out 3 days ago. - **HCW Biologics** (NASDAQ:HCWB) shares rose 10.79% to $2.36. The market value of their outstanding shares is at $4.0 million. As per the news, the Q2 earnings report came out 2 days ago. - **Pulmonx** (NASDAQ:LUNG) shares moved upwards by 7.52% to $2.43. The company's market cap stands at $95.7 million. - **Curis** (NASDAQ:CRIS) shares increased by 6.43% to $1.81. The market value of their outstanding shares is at $4.3 million. As per the news, the Q2 earnings report came out 2 days ago. - **Apimeds Pharmaceuticals** (AMEX:APUS) stock rose 6.0% to $4.24. The market value of their outstanding shares is at $6.4 million. As per the press release, Q2 earnings came out 2 days ago. - **Longeveron** (NASDAQ:LGVN) shares moved upwards by 5.43% to $0.83. The company's market cap stands at $26.1 million. As per the news, the Q2 earnings report came out 4 days ago. ### Losers - **IM Cannabis** (NASDAQ:IMCC) stock decreased by 13.7% to $0.09 during Tuesday's after-market session. The company's, Q2 earnings came out 3 days ago. - **Akso Health** (NASDAQ:AHG) shares decreased by 11.22% to $0.95. The market value of their outstanding shares is at $664.5 million. - **SILO Pharma** (NASDAQ:SILO) shares fell 9.78% to $2.77. The company's market cap stands at $3.4 million. The company's, Q2 earnings came out 3 days ago. - **Tvardi Therapeutics** (NASDAQ:TVRD) shares fell 8.95% to $1.73. The company's market cap stands at $24.8 million. The company's, Q2 earnings came out 2 days ago. - **OSR Health** (NASDAQ:OSRH) shares decreased by 8.33% to $0.39. The market value of their outstanding shares is at $20.7 million. As per the news, the Q2 earnings report came out 2 days ago. - **Liminatus Pharma** (NASDAQ:LIMN) shares fell 7.7% to $0.12. The market value of their outstanding shares is at $9.4 million. The company's, Q2 earnings came out 2 days ago. **See Also:** www.benzinga.com/money/best-healthcare-stocks/ This article was generated by Benzinga's automated content engine and reviewed by an editor. ### Related Stocks - [IMCC.US](https://longbridge.com/en/quote/IMCC.US.md) - [AHG.US](https://longbridge.com/en/quote/AHG.US.md) - [LUNG.US](https://longbridge.com/en/quote/LUNG.US.md) - [LGVN.US](https://longbridge.com/en/quote/LGVN.US.md) - [TNON.US](https://longbridge.com/en/quote/TNON.US.md) - [CRIS.US](https://longbridge.com/en/quote/CRIS.US.md) - [APUS.US](https://longbridge.com/en/quote/APUS.US.md) - [HCWB.US](https://longbridge.com/en/quote/HCWB.US.md) - [SILO.US](https://longbridge.com/en/quote/SILO.US.md) - [TVRD.US](https://longbridge.com/en/quote/TVRD.US.md) - [OSRH.US](https://longbridge.com/en/quote/OSRH.US.md) - [LIMN.US](https://longbridge.com/en/quote/LIMN.US.md) - [TNONW.US](https://longbridge.com/en/quote/TNONW.US.md) - [OSRHW.US](https://longbridge.com/en/quote/OSRHW.US.md) - [LIMNW.US](https://longbridge.com/en/quote/LIMNW.US.md) ## Related News & Research - [Curis prices USD 5.6 million public offering at USD 1.5 per share with warrants](https://longbridge.com/en/news/295794748.md) - [LGVN: Q2 2026 net loss rose to $6.1M as HLHS trial data and XPRIZE finalist status drive near-term focus](https://longbridge.com/en/news/295713291.md) - [Apimeds Pharmaceuticals US Enters Assignment And Transfer Agreement With Freet On August 19](https://longbridge.com/en/news/296655292.md) - [Silo Pharma says Canada issues notice of allowance for SPC-15 PTSD patent application](https://longbridge.com/en/news/296265804.md) - [Silo Pharma issues 165,000 unregistered shares in asset purchase deal](https://longbridge.com/en/news/296402385.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**